- Home
- CMPS vs EQV Comparison
CMPS vs EQV Comparison
Compare CMPS & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- EQV
- Stock Information
- Founded
- CMPS 2020
- EQV 2024
- Country
- CMPS United Kingdom
- EQV United States
- Employees
- CMPS 166
- EQV N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- EQV
- Sector
- CMPS Health Care
- EQV
- Exchange
- CMPS Nasdaq
- EQV Nasdaq
- Market Cap
- CMPS 502.7M
- EQV 461.8M
- IPO Year
- CMPS 2020
- EQV 2024
- Fundamental
- Price
- CMPS $5.20
- EQV $10.41
- Analyst Decision
- CMPS Strong Buy
- EQV
- Analyst Count
- CMPS 7
- EQV 0
- Target Price
- CMPS $17.00
- EQV N/A
- AVG Volume (30 Days)
- CMPS 1.8M
- EQV 18.2K
- Earning Date
- CMPS 10-30-2025
- EQV 01-01-0001
- Dividend Yield
- CMPS N/A
- EQV N/A
- EPS Growth
- CMPS N/A
- EQV N/A
- EPS
- CMPS N/A
- EQV N/A
- Revenue
- CMPS N/A
- EQV N/A
- Revenue This Year
- CMPS N/A
- EQV N/A
- Revenue Next Year
- CMPS N/A
- EQV N/A
- P/E Ratio
- CMPS N/A
- EQV $50.71
- Revenue Growth
- CMPS N/A
- EQV N/A
- 52 Week Low
- CMPS $2.25
- EQV $9.88
- 52 Week High
- CMPS $7.53
- EQV $10.74
- Technical
- Relative Strength Index (RSI)
- CMPS 63.09
- EQV 56.42
- Support Level
- CMPS $5.01
- EQV $10.33
- Resistance Level
- CMPS $5.33
- EQV $10.41
- Average True Range (ATR)
- CMPS 0.32
- EQV 0.03
- MACD
- CMPS 0.04
- EQV 0.01
- Stochastic Oscillator
- CMPS 81.63
- EQV 100.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.